Old Web
English
Sign In
Acemap
>
Paper
>
PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA
PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA
2007
Jc Sambrook
Adrian R. Levy
K Osenenko
C. Kindundu
M. Barbeau
Keywords:
Intensive care medicine
Osteoarthritis
Physical therapy
Celecoxib
Medicine
Lumiracoxib
cost effectiveness
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]